Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Key clinical findings for 2.4mg dose: Around 85% of people lost more than 5% of their body weight 66% of people lost more than 10% of their body weight 48% of people lost more than 15% of their body weight 30% of people lost more than 20% of their body weight These results show that Wegovy doesn't just support short-term changes, it can play a major role in achieving long-term, sustainable weight loss when used consistently and correctly
If further control is needed after at least 4 weeks on the 1 mg dose, the dose may be increased to the maximum dose of 2 mg once a week
The first is the nutritional gap argument described above
Access currently occurs through select specialized providers, compounded pharmacies licensed under 503A regulations, and ongoing clinical research programs, making availability geographically and clinically variable
The trial involved participants who had previously reached a body weight plateau
Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome
